Difference between revisions of "Team:AHUT China/HP/Gold"

Line 403: Line 403:
 
<p style="position:absolute;margin:10px;font-size:2em;font-family:Segoe UI;font-weight:500;position:relative;letter-spacing:0em;margin-left:0%;color:red">2.Improve the function OR characterization of a previously existing BioBrick Part or Device (created by another team, or by your own team in in a previous year of iGEM), and enter this information in the part's page on the Registry. Please see the Registry Contribution help page for help on documenting a contribution to an existing part. This part must NOT come from your team's 2016 range of part numbers.</p>
 
<p style="position:absolute;margin:10px;font-size:2em;font-family:Segoe UI;font-weight:500;position:relative;letter-spacing:0em;margin-left:0%;color:red">2.Improve the function OR characterization of a previously existing BioBrick Part or Device (created by another team, or by your own team in in a previous year of iGEM), and enter this information in the part's page on the Registry. Please see the Registry Contribution help page for help on documenting a contribution to an existing part. This part must NOT come from your team's 2016 range of part numbers.</p>
  
<p style="font-size:2em;font-weight:lighter;font-family:Segoe UI;line-height:1;text-indent:2rem">In the project of AHUT_China in 2014, we built the shortest path calculation model based on DNA calculation, and illustrated the principle of calculation through a planning case of navigation pathway. But, this year, We have furthered study based on the path planning problem to be solved in 2014. BBa_K1341020-Solution24578, is the shortest pathway in the project of 2014 of AHUT-China, which Node NO.5 is a necessary node to be passed in order to get to Node NO.8. However, in our project of this year, we don’t have to pass Site NO.5 while taking Site NO.2 as the start point and Site NO.8 as the terminal, which provides us with more diverse pathway choices and more conforms to the real situation. In our project of 2016, the DNA single strands of the sites and lines are connected by bridging-PCR. 12 information bits are added to the DNA single strand of the lines, which the pre-4bp sequences contain the information of identification point, the mid-4bp sequences contain the information of the specified line, and the post-4bp contain the information of the path length. In order to obtain Solution24578, it needs to construct recombinant plasmid in every possible pathway. And then the recombinant plasmid was inserted in E.coli, where the fluorescent protein gene in Node NO.5 get expressed. Thus, all the pathways passing Node NO.5 screened out. By contrast, we don’t have to go through a series of complex process like what have been depicted above in order to obtain the shortest pathway <2-6-8> in this year.</p>
+
<p style="font-size:2em;font-weight:lighter;font-family:Segoe UI;line-height:1;text-indent:2rem"><a href="http://parts.igem.org/Part:BBa_K1341020">In the project of AHUT_China in 2014, we built the shortest path calculation model based on DNA calculation, and illustrated the principle of calculation through a planning case of navigation pathway. But, this year, We have furthered study based on the path planning problem to be solved in 2014. BBa_K1341020-Solution24578, is the shortest pathway in the project of 2014 of AHUT-China, which Node NO.5 is a necessary node to be passed in order to get to Node NO.8. However, in our project of this year, we don’t have to pass Site NO.5 while taking Site NO.2 as the start point and Site NO.8 as the terminal, which provides us with more diverse pathway choices and more conforms to the real situation. In our project of 2016, the DNA single strands of the sites and lines are connected by bridging-PCR. 12 information bits are added to the DNA single strand of the lines, which the pre-4bp sequences contain the information of identification point, the mid-4bp sequences contain the information of the specified line, and the post-4bp contain the information of the path length. In order to obtain Solution24578, it needs to construct recombinant plasmid in every possible pathway. And then the recombinant plasmid was inserted in E.coli, where the fluorescent protein gene in Node NO.5 get expressed. Thus, all the pathways passing Node NO.5 screened out. By contrast, we don’t have to go through a series of complex process like what have been depicted above in order to obtain the shortest pathway <2-6-8> in this year.</a></p>
  
  
 
<p style="position:absolute;margin:10px;font-size:2em;font-family:Segoe UI;font-weight:500;position:relative;letter-spacing:0em;margin-left:0%;color:red">3.Demonstrate a functional proof of concept of your project. Your proof of concept must consist of a BioBrick device; a single BioBrick part cannot constitute a proof of concept. (Remember, biological materials may not be taken outside the lab.)</p>
 
<p style="position:absolute;margin:10px;font-size:2em;font-family:Segoe UI;font-weight:500;position:relative;letter-spacing:0em;margin-left:0%;color:red">3.Demonstrate a functional proof of concept of your project. Your proof of concept must consist of a BioBrick device; a single BioBrick part cannot constitute a proof of concept. (Remember, biological materials may not be taken outside the lab.)</p>
  
<p style="font-size:2em;font-weight:lighter;font-family:Segoe UI;line-height:1;text-indent:2rem">We made some contacts with some navigation companies in order to put our project into practice and bring the function of finding the shortest pathway through bio-computing into full play. Auto Navi map received our phone call and we introduced our project to them. The way we validated the two Bio-brick, BBa_K2044000 and BBa_K204401 corresponds to the way the map advises people to take the shortest pathway plan, which the company showed great interests in our project and encouraged us to further develop our project so that the general public can afford to use it in the real life. When our project is ready to be popularized to the general public, they would love to cooperate with us. In this process, we become familiar with the operating model of some navigation companies, which make us realize what else we should do to achieve the commercial value of our project.
+
<p style="font-size:2em;font-weight:lighter;font-family:Segoe UI;line-height:1;text-indent:2rem"><a href="https://2016.igem.org/Team:AHUT_China/Proof">We made some contacts with some navigation companies in order to put our project into practice and bring the function of finding the shortest pathway through bio-computing into full play. Auto Navi map received our phone call and we introduced our project to them. The way we validated the two Bio-brick, BBa_K2044000 and BBa_K204401 corresponds to the way the map advises people to take the shortest pathway plan, which the company showed great interests in our project and encouraged us to further develop our project so that the general public can afford to use it in the real life. When our project is ready to be popularized to the general public, they would love to cooperate with us. In this process, we become familiar with the operating model of some navigation companies, which make us realize what else we should do to achieve the commercial value of our project.
</p>
+
</a></p>
  
<p style="position:absolute;margin:10px;font-size:2em;font-family:Segoe UI;font-weight:500;position:relative;letter-spacing:0em;margin-left:0%;color:red">4.Show your project working under real-world conditions. To achieve this criterion, you should demonstrate your whole system, or a functional proof of concept working under simulated conditions in the lab (Remember, biological materials may not be taken outside the lab.)</p>
+
<p style="position:absolute;margin:10px;font-size:2em;font-family:Segoe UI;font-weight:500;position:relative;letter-spacing:0em;margin-left:0%;color:red"><a href="https://2016.igem.org/Team:AHUT_China/Demonstrate">4.Show your project working under real-world conditions. To achieve this criterion, you should demonstrate your whole system, or a functional proof of concept working under simulated conditions in the lab (Remember, biological materials may not be taken outside the lab.)</a></p>
  
 
<p style="font-size:2em;font-weight:lighter;font-family:Segoe UI;line-height:1;text-indent:2rem;color:blue">
 
<p style="font-size:2em;font-weight:lighter;font-family:Segoe UI;line-height:1;text-indent:2rem;color:blue">

Revision as of 16:56, 19 October 2016

Document